Polar Capital Biotech R Inc

Performance History30/11/2018
Growth of 1,000 (EUR)
Polar Capital Biotech R Inc
Fund68.025.2-5.114.311.4
+/-Cat19.55.812.08.38.4
+/-Idx19.05.34.410.53.3
 
Key Stats
NAV
11/12/2018
 USD 21.96
Day Change 0.83%
Morningstar Category™ Sector Equity Biotechnology
ISIN IE00B3XLHR60
Fund Size (Mil)
30/11/2018
 USD 478.59
Share Class Size (Mil)
11/12/2018
 USD 155.73
Max Initial Charge 5.00%
Ongoing Charge
15/02/2018
  1.73%
Investment Objective: Polar Capital Biotech R Inc
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation.
Returns
Trailing Returns (GBP)11/12/2018
YTD7.65
3 Years Annualised7.55
5 Years Annualised21.17
10 Years Annualised-
12 Month Yield 0.00
Dividend Paying Frequency Annually
Management
Manager Name
Start Date
David Pinniger
31/10/2013
Inception Date
31/10/2013
Advertisement
Benchmarks
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMSCI World/Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNo
GrowthYes
IncomeNo
HedgingNo
OtherNot Specific
Portfolio Profile for  Polar Capital Biotech R Inc31/10/2018
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks86.250.0086.25
Bonds0.000.000.00
Cash13.750.0013.75
Other0.000.000.00
Top 5 Regions%
United States76.07
Eurozone15.16
United Kingdom4.23
Europe - ex Euro4.16
Australasia0.38
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Alexion Pharmaceuticals IncHealthcareHealthcare7.34
Regeneron Pharmaceuticals IncHealthcareHealthcare5.56
Incyte CorpHealthcareHealthcare5.30
Amgen IncHealthcareHealthcare5.05
Biogen IncHealthcareHealthcare4.82
Polar Capital Biotech R Inc